Primary mediastinal B-cell lymphoma: Treatment and therapeutic targets

References

• Haioun C, Gaulard P, Roudot-Thoraval F, Divine M, Jouault H, Lebourgeois J P, et al. Mediastinal diffuse large-cell lymphoma with sclerosis: a condition with a poor prognosis. Am J Clin Oncol 1989; 12: 425–429
   PubMed Web of Science ®Google Scholar
• Lazzarino M, Orlandi E, Paulli M, Boveri E, Morra E, Brusamolino E, et al. Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumour with distinctive clinical and pathologic features. J Clin Oncol 1993; 11: 2306–2313
   PubMed Web of Science ®Google Scholar
• Todeschini G, Ambrosetti A, Meneghini V, Pizzolo G, Menestrina F, Chilosi M, et al. Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients. J Clin Oncol 1990; 8: 804–808
   PubMed Web of Science ®Google Scholar
• Lavabre-Bertrand T, Donadio D, Fegueux N, Jessueld D, Taib J, Charlier D, et al. A study of 15 cases of primary mediastinal lymphoma of B-cell type. Cancer 1992; 69: 2561–2566
   PubMed Web of Science ®Google Scholar
• Savage K J, Monti S, Kutok J L, Cattoretti G, Neuberg D, De Leval L, et al. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003; 102: 3871–3879
   PubMed Web of Science ®Google Scholar
• Rosenwald A, Wright G, Leroy K, Yu X, Gaulard P, Gascoyne R D, et al. Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 2003; 198: 851–862
   PubMed Web of Science ®Google Scholar
• Rodriguez J, Pugh W C, Romaguera J E, Cabanillas F. Primary mediastinal large cell lymphoma. Hematol Oncol 1994; 12: 175–184
   PubMed Web of Science ®Google Scholar
• Banks P M, Warnke R A. Mediastinal (thymic) large B-cell lymphoma. World Health Organization Classification of Tumours. Pathology and genetics of Tumours of Hematopoietic and Lymphoid Tissues, E S Jaffe, N L Harris, H Stein. IARC Press, Lyon 2001
   Google Scholar
• Miller J B, Variakojis D, Bitran J D, Sweet D L, Kinzie J J, Golomb H M, et al. Diffuse histiocytic lymphoma with sclerosis: a clinicopathologic entity frequently causing superior venacaval obstruction. Cancer 1981; 47: 748–756
   PubMed Web of Science ®Google Scholar
• Trump D L, Mann R B. Diffuse large cell and undifferentiated lymphomas with prominent mediastinal involvement. Cancer 1982; 50: 277–282
   PubMed Web of Science ®Google Scholar
• Levitt L J, Aisenberg A C, Harris N L, Linggood R M, Poppema S. Primary non-Hodgkin's lymphoma of the mediastinum. Cancer 1982; 50: 2486–2492
   PubMed Web of Science ®Google Scholar
• Rodriguez J, Pugh W C, Romaguera J E, Luthra R, Hagemeister F B, McLaughlin P, et al. Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoural mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase. Ann Oncol 1994; 5: 847–849
   PubMed Web of Science ®Google Scholar
• Scarpa A, Borgato L, Chilosi M, Capelli P, Menestrina F, Bonetti F, et al. Evidence of c-myc gene abnormalities in mediastinal large B-cell lymphoma of young adult age. Blood 1991; 78: 780–788
   PubMed Web of Science ®Google Scholar
• Joos S, Otano-Joos M I, Ziegler S, Bruderlein S, du Manoir S, Bentz M, et al. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 1996; 87: 1571–1578
   PubMed Web of Science ®Google Scholar
• Scarpa A, Taruscio D, Scardoni M, Iosi F, Paradisi S, Ennas M G, et al. Nonrandom chromosomal imbalances in primary mediastinal B-cell lymphoma detected by arbitrarily primed PCR fingerprinting. Genes Chromosomes Cancer 1999; 26: 203–209
   PubMed Web of Science ®Google Scholar
• Melzner I, Bucur A J, Bruderlein S, Dorsch K, Hasel C, Barth T F, et al. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. Blood 2005; 105: 2535–2542
   PubMed Web of Science ®Google Scholar
• Mestre C, Rubio-Moscardo F, Rosenwald A, Climent J, Dyer M J, Staudt L, et al. Homozygous deletion of SOCS1 in primary mediastinal B-cell lymphoma detected by CGH to BAC microarrays. Leukemia 2005; 19: 1082–1084
   PubMed Web of Science ®Google Scholar
• Traverse-Glehen A, Pittaluga S, Gaulard P, Sorbara L, Alonso M A, Raffeld M, et al. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol 2005; 29: 1411–1421
   PubMed Web of Science ®Google Scholar
• Garcia J F, Mollejo M, Fraga M, Forteza J, Muniesa J A, Perez-Guillermo M, et al. Large B-cell lymphoma with Hodgkin's features. Histopathology 2005; 47: 101–110
   PubMed Web of Science ®Google Scholar
• Copie-Bergman C, Gaulard P, Maouche-Chretien L, Briere J, Haioun C, Alonso M A, et al. The MAL gene is expressed in primary mediastinal large B-cell lymphoma. Blood 1999; 94: 3567–3575
   PubMed Web of Science ®Google Scholar
• Hsi E D, Sup S J, Alemany C, Tso E, Skacel M, Elson P, et al. MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis. Am J Clin Pathol 2006; 125: 776–782
   PubMed Web of Science ®Google Scholar
• Freeman G J, Long A J, Iwai Y, Bourque K, Chernova T, Nishimura H, et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192: 1027–1034
   PubMed Web of Science ®Google Scholar
• Latchman Y, Wood C R, Chernova T, Chaudhary D, Borde M, Chernova I, et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001; 2: 261–268
   PubMed Web of Science ®Google Scholar
• Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 2005; 207: 243–249
   PubMed Web of Science ®Google Scholar
• Alizadeh A A, Eisen M B, Davis R E, Ma C, Lossos I S, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–511
   PubMed Web of Science ®Google Scholar
• Pileri S A, Gaidano G, Zinzani P L, Falini B, Gaulard P, Zucca E, et al. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB 1, and PU.1 in the absence of immunoglobulins. Am J Pathol 2003; 162: 243–253
   PubMed Web of Science ®Google Scholar
• Guiter C, Dusanter-Fourt I, Copie-Bergman C, Boulland M L, Le Gouvello S, Gaulard P, et al. Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma. Blood 2004; 104: 543–549
   PubMed Web of Science ®Google Scholar
• Niiro H, Clark E A. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol 2002; 2: 945–956
   PubMed Web of Science ®Google Scholar
• Banham A H, Beasley N, Campo E, Fernandez P L, Fidler C, Gatter K, et al. The FOXP1 winged helix transcription factor is a novel candidate tumour suppressor gene on chromosome 3p. Cancer Res 2001; 61: 8820–8829
   PubMed Web of Science ®Google Scholar
• Skinnider B F, Elia A J, Gascoyne R D, Trumper L H, von Bonin F, Kapp U, et al. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2001; 97: 250–255
   PubMed Web of Science ®Google Scholar
• Ohshima K, Akaiwa M, Umeshita R, Suzumiya J, Izuhara K, Kikuchi M. Interleukin-13 and interleukin-13 receptor in Hodgkin's disease: possible autocrine mechanism and involvement in fibrosis. Histopathology 2001; 38: 368–375
   PubMed Web of Science ®Google Scholar
• Copie-Bergman C, Boulland M L, Dehoulle C, Moller P, Farcet J P, Dyer M J, et al. Interleukin 4-induced gene 1 is activated in primary mediastinal large B-cell lymphoma. Blood 2003; 101: 2756–2761
   PubMed Web of Science ®Google Scholar
• Peh S C, Kim L H, Poppema S. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma. Am J Surg Pathol 2001; 25: 925–929
   PubMed Web of Science ®Google Scholar
• Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982; 299: 65–67
   PubMed Web of Science ®Google Scholar
• Feuerhake F, Kutok J L, Monti S, Chen W, LaCasce A S, Cattoretti G, et al. NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. Blood 2005; 106: 1392–1399
   PubMed Web of Science ®Google Scholar
• de Leval L, Ferry J A, Falini B, Shipp M, Harris N L. Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells?. Am J Surg Pathol 2001; 25: 1277–1282
   PubMed Web of Science ®Google Scholar
• Weniger M A, Pulford K, Gesk S, Ehrlich S, Banham A H, Lyne L, et al. Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma. Leukemia 2006; 20: 1880–1882
   PubMed Web of Science ®Google Scholar
• Hsu F J, Levy R. Preferential use of the VH4 Ig gene family by diffuse large-cell lymphoma. Blood 1995; 86: 3072–3082
   PubMed Web of Science ®Google Scholar
• Kuppers R, Klein U, Hansmann M L, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med 1999; 341: 1520–1529
   PubMed Web of Science ®Google Scholar
• Kuppers R, Rajewsky K, Hansmann M L. Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression. Eur J Immunol 1997; 27: 1398–1405
   PubMed Web of Science ®Google Scholar
• Malpeli G, Barbi S, Moore P S, Scardoni M, Chilosi M, Scarpa A, et al. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas. Haematologica 2004; 89: 1091–1099
   PubMed Web of Science ®Google Scholar
• Staudt L M, Dave S. The biology of human lymphoid malignancies revealed by gene expression profiling. Adv Immunol 2005; 87: 163–208
   PubMed Web of Science ®Google Scholar
• Takahashi H, Feuerhake F, Monti S, Kutok J L, Aster J C, Shipp M A. Lack of IKBA coding region mutations in primary mediastinal large B-cell lymphoma and the host response subtype of diffuse large B-cell lymphoma. Blood 2006; 107: 844–845
   PubMed Web of Science ®Google Scholar
• Calvo K R, Traverse-Glehen A, Pittaluga S, Jaffe E S. Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma. Adv Anat Pathol 2004; 11: 227–238
   PubMed Web of Science ®Google Scholar
• Zamo A, Malpeli G, Scarpa A, Doglioni C, Chilosi M, Menestrina F. Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas. Mod Pathol 2005; 18: 1448–1453
   PubMed Web of Science ®Google Scholar
• Todeschini G, Secchi S, Morra E, Vitolo U, Orlandi E, Pasini F, et al. Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B. Br J Cancer 2004; 90: 372–376
   PubMed Web of Science ®Google Scholar
• Zinzani P L, Martelli M, Bertini M, Gianni A M, Devizzi L, Federico M, et al. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients. Haematologica 2002; 87: 1258–1264
   PubMed Web of Science ®Google Scholar
• Savage K J, Al-Rajhi N, Voss N, Paltiel C, Klasa R, Gascoyne R D, et al. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience. Ann Oncol 2006; 17: 123–130
   PubMed Web of Science ®Google Scholar
• Hamlin P A, Portlock C S, Straus D J, Noy A, Singer A, Horwitz S M, et al. Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999. Br J Haematol 2005; 130: 691–699
   PubMed Web of Science ®Google Scholar
• Romaguera J E, Rodriguez Diaz-Pavon J, Carias L, Hagemeister F B, McLaughlin P, Rodriguez M A, et al. Use of the international prognostic index and the tumour score to detect poor-risk patients with primary mediastinal large B-cell lymphoma: a study of 37 previously untreated patients. Leuk Lymphoma 1998; 28: 295–306
   PubMed Web of Science ®Google Scholar
• Rodriguez J, Cabanillas F, McLaughlin P, Swan F, Rodriguez M, Hagemeister F, et al. A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the ‘tumour score’. Ann Oncol 1992; 3: 711–717
   PubMed Web of Science ®Google Scholar
• Rodriguez J, Conde E, Gutierrez A, Garcia-Ruiz J C, Lahuerta J J, Varela M R, et al. Front-line autologous stem cell transplantation (ASCT) in primary mediastinal large B-cell lymphoma: the GEL-TAMO experience. Blood 2006; 108: 3056
   Google Scholar
• Lazzarino M, Orlandi E, Paulli M, Strater J, Klersy C, Gianelli U, et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol 1997; 15: 1646–1653
   PubMed Web of Science ®Google Scholar
• Zinzani P L, Martelli M, Bendandi M, De Renzo A, Zaccaria A, Pavone E, et al. Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy. Haematologica 2001; 86: 187–191
   PubMed Web of Science ®Google Scholar
• Fisher R I, Gaynor E R, Dahlberg S, Oken M M, Grogan T M, Mize E M, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002–1006
   PubMed Web of Science ®Google Scholar
• Dunleavy K, Pittaluga S, Janik J, Grant N, Steinberg S, Staudt L, et al. Primary mediastinal large B-cell lymphoma (PMBL) outcome is significantly improved by the addition of rituximab to dose adjusted (DA)-EPOCH and overcomes the need for radiation. Blood 2005; 106: 929
   PubMed Web of Science ®Google Scholar
• Zinzani P L, Martelli M, Magagnoli M, Pescarmona E, Scaramucci L, Palombi F, et al. Treatment and clinical management of primary mediastinal large B-cell lymphoma with sclerosis: MACOP-B regimen and mediastinal radiotherapy monitored by (67)Gallium scan in 50 patients. Blood 1999; 94: 3289–3293
   PubMed Web of Science ®Google Scholar
• Bieri S, Roggero E, Zucca E, Bertoni F, Pianca S, Sanna P, et al. Primary mediastinal large B-cell lymphoma (PMLCL): the need for prospective controlled clinical trials. Leuk Lymphoma 1999; 35: 139–146
   PubMed Web of Science ®Google Scholar
• Kirn D, Mauch P, Shaffer K, Pinkus G, Shipp M A, Kaplan W D, et al. Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients. J Clin Oncol 1993; 11: 1336–1343
   PubMed Web of Science ®Google Scholar
• Cazals-Hatem D, Lepage E, Brice P, Ferrant A, d'Agay M F, Baumelou E, et al. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (“Groupe d'Etude des Lymphomes de l'Adulte”) study. Am J Surg Pathol 1996; 20: 877–888
   PubMed Web of Science ®Google Scholar
• Adams M J, Lipsitz S R, Colan S D, Tarbell N J, Treves S T, Diller L, et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 2004; 22: 3139–3148
   PubMed Web of Science ®Google Scholar
• Sehn L H, Antin J H, Shulman L N, Mauch P, Elias A, Kadin M E, et al. Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation. Blood 1998; 91: 717–723
   PubMed Web of Science ®Google Scholar
• Vose J M, Bierman P J, Anderson J R, Harrison K A, Dalrymple G V, Byar K, et al. Single-photon emission computed tomography gallium imaging versus computed tomography: predictive value in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation for non-Hodgkin's lymphoma. J Clin Oncol 1996; 14: 2473–2479
   PubMed Web of Science ®Google Scholar
• Popat U, Przepiork D, Champlin R, Pugh W, Amin K, Mehra R, et al. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome. J Clin Oncol 1998; 16: 63–69
   PubMed Web of Science ®Google Scholar
• Nademanee A, Molina A, O'Donnell M R, Dagis A, Snyder D S, Parker P, et al. Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk group. Blood 1997; 90: 3844–3852
   PubMed Web of Science ®Google Scholar
• Rodriguez J, Caballero M D, Gutierrez A, Solano C, Arranz R, Lahuerta J J, et al. Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience. Ann Oncol 2004; 15: 1504–1509
   PubMed Web of Science ®Google Scholar
• Rodriguez J. Should rituximab be used prior to autologous stem-cell transplantation for non-Hodgkin's lymphoma?. Nat Clin Pract Oncol 2005; 2: 74–75
   PubMedGoogle Scholar
• Moskowitz C, Hamlin P A, Horwitz S M, Noy A, O'Connor O A, Palomba M, et al. Phase II trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL. Blood 2006; 108: 532
   Google Scholar
• Dupuis J, Gaulard P, Hemery F, Itti E, Gisselbrecht C, Rahmouni A, et al. Respective prognostic values of germinal center phenotype and early (18)fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma. Haematologica 2007; 92: 778–783
   PubMed Web of Science ®Google Scholar
• Haioun C, Itti E, Rahmouni A, Brice P, Rain J D, Belhadj K, et al. [18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 2005; 106: 1376–1381
   PubMed Web of Science ®Google Scholar
• Sanchez-Beato M, Sanchez-Aguilera A, Piris M A. Cell cycle deregulation in B-cell lymphomas. Blood 2003; 101: 1220–1235
   PubMed Web of Science ®Google Scholar
• Jacobson J O, Aisenberg A C, Lamarre L, Willett C G, Linggood R M, Miketic L M, et al. Mediastinal large cell lymphoma. An uncommon subset of adult lymphoma curable with combined modality therapy. Cancer 1988; 62: 1893–1898
   PubMed Web of Science ®Google Scholar
• Bertini M, Orsucci L, Vitolo U, Levis A, Todeschini G, Meneghini V, et al. Stage II large B-cell lymphoma with sclerosis treated with MACOP-B. Ann Oncol 1991; 2: 733–737
   PubMed Web of Science ®Google Scholar
• Falini B, Venturi S, Martelli M, Santucci A, Pileri S, Pescarmona E, et al. Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. Br J Haematol 1995; 89: 780–789
   PubMed Web of Science ®Google Scholar
• Zinzani P L, Bendandi M, Frezza G, Gherlinzoni F, Merla E, Salvucci M, et al. Primary Mediastinal B-cell lymphoma with sclerosis: clinical and therapeutic evaluation of 22 patients. Leuk Lymphoma 1996; 21: 311–316
   PubMed Web of Science ®Google Scholar
• Martelli M P, Martelli M, Pescarmona E, De Sanctis V, Donato V, Palombi F, et al. MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis. Ann Oncol 1998; 9: 1027–1029
   PubMed Web of Science ®Google Scholar
• Abou-Elella A A, Weisenburger D D, Vose J M, Kollath J P, Lynch J C, Bast M A, et al. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group. J Clin Oncol 1999; 17: 784–790
   PubMed Web of Science ®Google Scholar
• Cairoli R, Grillo G, Tedeschi A, Gargantini L, Marenco P, Tresoldi E, et al. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis. Bone Marrow Transplant 2002; 29: 473–477
   PubMed Web of Science ®Google Scholar